Measuring immune control of tuberculosis
Part of Infections clinical trials.
This study looks at how well your immune system controls tuberculosis (TB) bacteria. It uses a blood test to measure immune responses in healthy people and those who have been vaccinated against TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy volunteer or planning to get a TB vaccine
- You do not have HIV
- You are a Swedish citizen
- You do not have long-term liver or kidney disease
- You are not taking medications that weaken the immune system (like steroids or chemotherapy)
- You do not have a condition that weakens your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study aims to better understand how the immune system responds to tuberculosis (TB) and improve tools for diagnosing and managing the disease. It may help people with active TB, their close contacts, people with certain other lung diseases, or healthy individuals.
This trial compares how well tuberculosis (TB) treatment works in people with healthy immune systems versus those with weakened immune systems. It looks at patients who already have a chronic chest condition.
This study examines how different types of mycobacterial infections (including tuberculosis) affect your body's immune response. Researchers will compare immune function across different TB types and drug-resistance patterns to better understand the disease and improve treatment.
This Phase 2 study tests MTBVAC, a TB vaccine candidate, to see if it is safe and whether it helps the immune system. It may be a fit if you’re eligible for TB and HIV-related vaccine safety testing and can follow study visits and testing.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.